A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.
The innate immune system employs Toll-like receptors (TLRs) for the detection of invading microorganisms based on distinct molecular patterns. For example, TLR9 is activated by microbial DNA and also by short therapeutic CpG-containing oligonucleotides (CpG-ODN). TLR9 activation leads to the product...
Egile Nagusiak: | Kubarenko, A, Ranjan, S, Rautanen, A, Mills, T, Wong, S, Vannberg, F, Neumaier, M, Bekeredjian-Ding, I, Hill, A, Ahmad-Nejad, P, Weber, A |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2010
|
Antzeko izenburuak
-
Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9
nork: Avalos, Ana M., et al.
Argitaratua: (2014) -
MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
nork: George, J, et al.
Argitaratua: (2010) -
Immunotherapeutic Potential of CpG Oligonucleotides in Chickens
nork: Arshud Dar, et al.
Argitaratua: (2009-04-01) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
nork: Hidekazu Shirota, et al.
Argitaratua: (2015-05-01) -
Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
nork: Tokuyuki Yoshida, et al.
Argitaratua: (2024-05-01)